Associated Papers
Heterozygous Pathogenic Variants in SERPINB7 Potentially Associated With Concomitant Moyamoya Angiopathy and Nagashima-Type Palmoplantar Keratoderma.
Kazerooni L et al.
American Journal of Medical Genetics. Part A, 2025
A deep intronic founder variant in the SERPINB7 gene causing aberrant splicing is a potential therapeutic target for Nagashima-type palmoplantar keratoderma.
Chen Y et al.
Journal of Dermatological Science, 2025
Investigation of Nagashima-type palmoplantar keratoderma in China: A cross-sectional study of 234 patients.
Liu J et al.
The Journal of Dermatology, 2023
Two novel mutations of SERPINB7 in eight cases of Nagashima-type palmoplantar keratosis in the Chinese population.
Xiao T et al.
The Journal of Dermatology, 2022
Nagashima-Type Palmoplantar Keratosis: Clinical Characteristics, Genetic Characterization, and Clinical Management.
Huang C et al.
Biomed Research International, 2021
[Nagashima-type palmoplantar keratoderma: A little-known palmoplantar keratoderma in Europe].
Chassain K et al.
Annales De Dermatologie Et De Venereologie, 2019
A sporadic case of Nagashima-type palmoplantar keratosis caused by gene mutation in SERPINB7.
Li CX et al.
Clinical and Experimental Dermatology, 2016
Identification of previously unknown SERPINB7 splice variants in patients with Nagashima-type palmoplantar keratosis reveals the importance of the CD-loop of SERPINB7.
Suzuki S et al.
The British Journal of Dermatology, 2015
Nagashima-Type Palmoplantar Keratosis with Compound Heterozygous Mutations in SERPINB7.
Songsantiphap C et al.
Case Reports in Dermatology, 0
Select a paper to view details